Pharmacological action: Combined drug. Tobramycin is an antibiotic from the aminoglycoside group produced by Streptococcus tenebrarius, has a wide spectrum of antibacterial action, is active against gram-positive and gram-negative microorganisms: Staphylococcus spp. (including Staphylococcus aureus, Staphylococcus epidermidis), including strains resistant to penicillin; Streptococcus spp., including some beta-hemolytic species of group A and non-hemolytic species, some Streptococcus pneumoniae; Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, Enterobacter aerogenes, Proteus mirabilis, Morganella morganii, most species of Proteus vulgaris, Haemophilus influenzae, Haemophilus aegyptius, Moraxella lacunata, Acinetobacter calcoaceticus (Herellea vaginacoia), some species of Neisseria spp. Dexamethasone – GCS, has anti-inflammatory, anti-allergic and desensitizing effects.
TobraDex® Indications: Blepharitis, conjunctivitis, keratitis (without damage to the epithelium); prevention of postoperative infections.
TobraDex® Contraindications: Hypersensitivity, viral diseases of the cornea and conjunctiva (including keratitis caused by Herpes simplex, chickenpox); eye tuberculosis; fungal diseases of the eyes; condition after removal of a foreign body of the cornea. With caution. Childhood, pregnancy, lactation.
Side effects: Allergic reactions (itching, swelling of the eyelids, conjunctival hyperemia); increased intraocular pressure; posterior subcapsular cataract, delayed wound healing; secondary infection.
Dosage and administration: Suspension: 1-2 drops into the conjunctival sac, every 4-6 hours. Ointment: 1.5 cm strip into the conjunctival sac, 3-4 times a day. You can combine the use of ointment and suspension.